WHO ICTRP trial
Exosome therapy of vitiligo
IRCT20210228050535N7 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20210228050535N7 |
|---|---|
| Public title | Exosome therapy of vitiligo |
| Scientific title | Investigating the safety and effectiveness of vitiligo treatment by injecting extracellular vesicles (exosome) derived from mesenchymal stem cells compared to fluocinolone IPA/50gr |
| Primary sponsor | Mazandaran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 1 |
| Countries | Iran (Islamic Republic of) |
| Conditions | vitiligo. Vitiligo |
| Interventions | Intervention group: A dose of 2 mg of exosomes will be injected subcutaneously into the target area on one side, while fluocinolone will be administered on the opposite side.. |
| Registration date | Oct 19, 2025 |
| Target size | 20 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: